At what heart rate is a permanent pacemaker recommended after Transcatheter Mitral Valve Replacement (TMVR) and what interventions are necessary?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Permanent Pacemaker Implantation After Transcatheter Valve Replacement: Indications and Interventions

Permanent pacemaker implantation is strongly recommended for patients who develop persistent high-grade AV block after transcatheter valve replacement that does not resolve before discharge. 1

Heart Rate Thresholds and Indications for Permanent Pacemaker

Absolute Indications for Permanent Pacemaker:

  • Persistent complete heart block that does not resolve within 24 hours 1
  • Symptomatic bradycardia of any severity 1
  • High-grade AV block (Mobitz type II or higher) that persists 1
  • Recurrent episodes of transient high-grade AV block during hospitalization, regardless of symptoms 1

High-Risk Features Requiring Closer Monitoring:

  • Pre-existing RBBB: Highest risk group with up to 24% chance of developing high-degree AV block 1, 2
  • New LBBB with PR/QRS prolongation ≥20 ms: Requires continued monitoring 1
  • Transient complete heart block during valve deployment: Requires at least 24 hours of monitoring 1

Management Algorithm Based on Conduction Disturbances

1. Patients with Persistent Complete Heart Block:

  • Maintain temporary pacemaker for at least 24 hours to assess for conduction recovery
  • If heart block persists, proceed with permanent pacemaker implantation before discharge 1

2. Patients with Pre-existing RBBB:

  • Highest risk group (up to 24% risk of high-degree AV block) 1, 2
  • If they develop any transient or persistent high-grade AV block, permanent pacemaker implantation is indicated in vast majority of cases 1
  • Maintain transvenous pacing ability with continuous cardiac monitoring for at least 24 hours 1

3. Patients with New-Onset LBBB:

  • Associated with increased risk of PPM implantation (RR: 1.89) 1
  • Permanent pacemaker may be considered (Class IIb recommendation) 1
  • Continue transvenous pacing for at least 24 hours with continuous cardiac monitoring 1
  • Approximately 50% will resolve at 6-12 months 1

4. Patients with Normal Conduction Post-Procedure:

  • Risk of delayed AV block is <1% 1
  • Temporary pacemaker can be removed immediately post-procedure
  • Continue cardiac monitoring for 24 hours and repeat ECG the following day 1

Interventions and Monitoring Strategies

Immediate Post-Procedure:

  • Rapid atrial pacing test (up to 120 bpm) to predict need for permanent pacing:
    • If Wenckebach AV block does not develop: Low risk (1.3%) of needing PPM
    • If Wenckebach AV block develops: Higher risk (13.1%) of needing PPM 1, 2

Temporary Pacing Options:

  • Permanent-temporary pacemaker (PTPM): Active-fixation lead with external pulse generator for patients with conduction abnormalities not meeting conventional PPM criteria 3
    • Allows time for assessment and may prevent unnecessary PPM implantation
    • Average duration of PTPM use: 2.3 days 3

Monitoring Duration:

  • High-risk patients (pre-existing RBBB, new LBBB): Minimum 24 hours of continuous cardiac monitoring 1, 2
  • Delayed high-grade AV block risk exists for up to 7 days, with higher risk for self-expanding valves 1
  • For patients with new conduction disturbances: Consider inpatient monitoring for at least 2 days and ambulatory monitoring for 14+ days post-discharge 2

Important Considerations and Pitfalls

Recovery of Conduction:

  • Recovery rates: 22-68% of patients receiving PPM may recover conduction within 10-30 days 4, 5
  • Low pacing requirements: 27% of patients with PPM had <1% ventricular pacing requirements during follow-up 3

Long-term Outcomes:

  • PPM implantation within 30 days post-valve replacement is associated with higher mortality and heart failure hospitalization during follow-up (HR 1.11) 6
  • Consider this risk when making decisions about PPM implantation in borderline cases

Specific to TMVR:

  • While most evidence focuses on TAVR, similar principles apply to TMVR patients 7
  • Monitor for conduction disturbances after TMVR as they can also lead to high-grade AV block requiring pacemaker implantation

Practical Implementation

  1. Assess baseline risk: Identify pre-existing conduction abnormalities (especially RBBB)
  2. Monitor post-procedure: Continuous cardiac monitoring with appropriate duration based on risk
  3. Perform daily ECGs: Track changes in PR and QRS intervals
  4. Consider atrial pacing test: To predict need for permanent pacing
  5. Implant PPM before discharge: For persistent high-grade AV block or recurrent episodes of transient high-grade AV block

Do not discharge high-risk patients (especially those with new LBBB or pre-existing RBBB) without adequate monitoring plans, as delayed high-grade AV block can occur with potentially fatal consequences. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Permanent Pacemaker Implantation After TAVR

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Permanent-temporary pacemakers in the management of patients with conduction abnormalities after transcatheter aortic valve replacement.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2018

Research

Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2018

Research

Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.